Delebarre M - Search Results

1

Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?

Delebarre M, Garnier N, Macher E, Thebaud E, Mazingue F, Leblond P, Duhamel A, Martinot A, Dubos F. Delebarre M, et al. J Pediatr Hematol Oncol. 2015 Nov;37(8):e468-74. doi: 10.1097/MPH.0000000000000440. J Pediatr Hematol Oncol. 2015. PMID: 26479996

2

Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.

Macher E, Dubos F, Garnier N, Delebarre M, De Berranger E, Thebaud E, Mazingue F, Leblond P, Martinot A. Macher E, et al. Among authors: delebarre m. Pediatr Blood Cancer. 2010 Oct;55(4):662-7. doi: 10.1002/pbc.22586. Pediatr Blood Cancer. 2010. PMID: 20806364

3

[Management of adrenocortical carcinomas in children].

Leblond P, Delebarre M, Aubert S. Leblond P, et al. Among authors: delebarre m. Bull Cancer. 2011 May;98(5):595-605. doi: 10.1684/bdc.2011.1357. Bull Cancer. 2011. PMID: 21596653 Review. French.

4

Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.

Dubos F, Delebarre M, Martinot A. Dubos F, et al. Among authors: delebarre m. Curr Opin Hematol. 2012 Jan;19(1):39-43. doi: 10.1097/MOH.0b013e32834da951. Curr Opin Hematol. 2012. PMID: 22123661 Review.

5

Optimization of continuous infusion of piperacillin-tazobactam in children with fever and neutropenia.

Delvallée M, Mazingue F, Abouchahla W, Delebarre M, Wallet F, Courcol R, Kipnis E, Dessein R. Delvallée M, et al. Among authors: delebarre m. Pediatr Infect Dis J. 2013 Sep;32(9):962-4. doi: 10.1097/INF.0b013e318298dfb8. Pediatr Infect Dis J. 2013. PMID: 23629023

6

[Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?].

Dubos F, Delebarre M, Lagrée M. Dubos F, et al. Among authors: delebarre m. Arch Pediatr. 2013 Nov;20 Suppl 3:S90-3. doi: 10.1016/S0929-693X(13)71415-5. Arch Pediatr. 2013. PMID: 24360309 French.

7

Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis.

Delebarre M, Macher E, Mazingue F, Martinot A, Dubos F. Delebarre M, et al. Pediatr Blood Cancer. 2014 Oct;61(10):1786-91. doi: 10.1002/pbc.25106. Epub 2014 Jun 29. Pediatr Blood Cancer. 2014. PMID: 24975886 Review.

8

[Evaluation of ambulatory prescribing for community-acquired pneumonia in children].

Dubos F, Delvart C, Mordacq C, Lagrée M, Delebarre M, Deschildre A, Martinot A. Dubos F, et al. Among authors: delebarre m. Arch Pediatr. 2014 Aug;21(8):827-33. doi: 10.1016/j.arcped.2014.05.011. Epub 2014 Jul 2. Arch Pediatr. 2014. PMID: 24997731 French.

9

Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.

Delebarre M, Tiphaine A, Martinot A, Dubos F. Delebarre M, et al. Pediatr Blood Cancer. 2016 Dec;63(12):2167-2172. doi: 10.1002/pbc.26121. Epub 2016 Aug 28. Pediatr Blood Cancer. 2016. PMID: 27569451

10

Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.

Delebarre M, Dessein R, Lagrée M, Mazingue F, Sudour-Bonnange H, Martinot A, Dubos F. Delebarre M, et al. J Infect. 2019 Aug;79(2):95-100. doi: 10.1016/j.jinf.2019.06.008. Epub 2019 Jun 19. J Infect. 2019. PMID: 31228471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters